Cover - USD ($) |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2024 |
Mar. 28, 2025 |
Jun. 30, 2024 |
|
| Document Type | 10-K/A | ||
| Amendment Flag | true | ||
| Amendment Description | Aimei Health Technology Co., Ltd (the “Company,” “we”, “our” or “us”) is filing this Amendment No. 1 (this “Amendment”) to the Annual Report on Form 10-K for the year ended December 31, 2024, originally filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 28, 2025 (the “Original Filing,” as amended by this Amendment, the “Annual Report”), as a comprehensive amendment to amend and restate its disclosures included in the Original Filing to include risk factor disclosures and related discussions concerning the People’s Republic of China (“PRC”), in response to the SEC comment letter dated July 31, 2025. Except as described above, this Amendment does not amend, update or change any other items or disclosures contained in the Original Filing, and, accordingly, this Amendment does not reflect or purport to reflect any information or events occurring after the date of the Original Filing or modify or update those disclosures affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Filing and the Company’s other filings with the SEC. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Original Filing. | ||
| Document Annual Report | true | ||
| Document Transition Report | false | ||
| Document Period End Date | Dec. 31, 2024 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2024 | ||
| Current Fiscal Year End Date | --12-31 | ||
| Entity File Number | 001-41880 | ||
| Entity Registrant Name | Aimei Health Technology Co., Ltd | ||
| Entity Central Index Key | 0001979005 | ||
| Entity Tax Identification Number | 00-0000000 | ||
| Entity Incorporation, State or Country Code | E9 | ||
| Entity Address, Address Line One | 10 East 53rd Street | ||
| Entity Address, Address Line Two | Suite 3001 | ||
| Entity Address, City or Town | New York | ||
| Entity Address, State or Province | NY | ||
| Entity Address, Postal Zip Code | 10022 | ||
| City Area Code | 86 | ||
| Local Phone Number | 13758131392 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Voluntary Filers | No | ||
| Entity Current Reporting Status | Yes | ||
| Entity Interactive Data Current | Yes | ||
| Entity Filer Category | Non-accelerated Filer | ||
| Entity Small Business | true | ||
| Entity Emerging Growth Company | true | ||
| Elected Not To Use the Extended Transition Period | false | ||
| Entity Shell Company | false | ||
| Entity Public Float | $ 71,415,000 | ||
| Entity Common Stock, Shares Outstanding | 6,121,733 | ||
| ICFR Auditor Attestation Flag | false | ||
| Document Financial Statement Error Correction [Flag] | false | ||
| Entity Listing, Par Value Per Share | $ 0.0001 | ||
| Auditor Firm ID | 206 | ||
| Auditor Opinion [Text Block] | We have audited the accompanying balance sheets of Aimei Health Technology Co., Ltd. (the “Company”) as of December 31, 2024 and 2023, and the related statements of operations, changes in shareholders’ deficit, and cash flows for the year ended December 31, 2024, and for the period from April 27, 2023 (inception) through December 31, 2023 , and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and December 31, 203, and the results of its operations and its cash flows for the year ended December 31, 2024, and for the period from April 27, 2023 (inception) through December 31, 2023, in conformity with accounting principles generally accepted in the United States of America. | ||
| Auditor Name | MaloneBailey, LLP | ||
| Auditor Location | Houston, Texas | ||
| Ordinary Shares, par value $0.0001 per share | |||
| Title of 12(b) Security | Ordinary Shares, par value $0.0001 per share | ||
| Trading Symbol | AFJK | ||
| Security Exchange Name | NASDAQ | ||
| Rights, exchangeable into one-fifth of one Ordinary Share | |||
| Title of 12(b) Security | Rights, exchangeable into one-fifth of one Ordinary Share | ||
| Trading Symbol | AFJKR | ||
| Security Exchange Name | NASDAQ | ||
| Units, each consisting of one Ordinary Share and one Right | |||
| Title of 12(b) Security | Units, each consisting of one Ordinary Share and one Right | ||
| Trading Symbol | AFJKU | ||
| Security Exchange Name | NASDAQ |